The 25-kDa heat-shock protein (Hsp25) is expressed in the cartilage of the growth plate and suggested to function in chondrocyte differentiation and degeneration. Using immunohistochemistry, we examined the temporal and spatial occurrence of Hsp25 in Meckel's cartilage in embryonic mice mandibles, and in other types of cartilage in both embryonic and adult mice. In adults, Hsp25 immunoreactivity was detected in the hypertrophic chondrocytes located in growth plates of long bones and in non-osteogenic laryngeal and tracheal cartilages. No chondrocytes in the resting or proliferating phase exhibited Hsp25 immunoreactivity. In the embryonic mandibles, resting and proliferating chondrocytes in the anterior and intermediate portions of Meckel's cartilage showed Hsp25 immunoreactivity from the 12th day of gestation (E12) through E15, whereas those in the posterior portion showed little or no immunoreactivity. After E16, the overall Hsp25 immunoreactivity in Meckel's cartilage substantially reduced in intensity, and little or no immunoreactivity was detected in the hypertrophic chondrocytes located in the degenerating portions of Meckel's cartilage. The antisense oligonucleotide for Hsp25 mRNA applied to the culture media of the mandibular explants from E10 embryos caused significant inhibition of the development of the anterior and middle portions of Meckel's cartilage. These results suggested that Hsp25 is essential for the development of Meckel's cartilage and plays different roles in Meckel's cartilage from those in the permanent cartilages and the cartilages undergoing endochondral ossification.
Introduction
In the embryonic mandible of vertebrates, Meckel's cartilage occurs provisionally prior to the formation of a permanent bony structure. Cranial neural crest cells that have migrated into the first branchial arch differentiate first to mesenchymal cells and further into chondroblasts forming Meckel's cartilage as well as the cells forming bone and dental tissues (Chai et al. 1994) . Development of Meckel's cartilage begins as a condensation of mesenchymal cells to form a precartilaginous blastema. In the rodents, Meckel's cartilage assumes symmetrical V-shaped rods fused at each anterior (distal) end, which extend straightly backward along the lateral margins of mandibular process of the first branchial arch and suddenly curve inward at their posterior (proximal) ends. On the other hand, membranous ossification of mandibular bone occurs at a site separated by the perichondrium and surrounding tissue layers from the Meckel's cartilage. The maturation process of the Meckel's cartilage takes place in its intermediate portion. Finally, the tissue of the Meckel's cartilage demonstrates signs of focal degeneration, followed by extensive resorption and complete disappearance of its anterior and intermediate portions. As the development and growth of mandibular bone proceed, the space occupied by the anterior portion of Meckel's cartilage is gradually replaced by bone tissues. The intermediate portion of Meckel' s cartilage is replaced with dense connective tissues of the sphenomandibular ligament. The disappearance of these cartilage portions occurs without any morphologically detectable reactions in the neighboring mesenchyme (Granström et al. 1988) . In contrast, the posterior portion of the cartilage undergoes endochondral ossification and converts to the bony structures of the middle ear, i.e., the malleus and incus (Zschäbitz et al. 1995) . As pointed out previously by Ishizeki et al. (1999) , the relationship between the membranous ossification of mandibular bone and degeneration of the anterior portion of Meckel's cartilage is still unclear since the osteogenesis and cartilaginous degeneration occur so close together spatially that they exhibit similar histological features to those of the growth plate undergoing endochondral ossification. Degenerating Meckel's cartilage contains hypertrophic chondrocytes and a calcified matrix accompanied by the expression of alkaline phosphatase activity and type X collagen. These phenomena are frequently noted in endochondral ossification. However, this degenerated cartilage disappears without giving rise to ossification. The molecular mechanism for the premature disappearance of Meckel's cartilage during the embryonic period, and its possible developmental role on the formation of permanent bone structure in the mandible have not yet been identified.
Recently, members of the family of heat-shock proteins (Hsp) have been found to be expressed specifically in the cartilage of the rodent growth plate (Otsuka et al. 1996; Vanmuylder et al. 1997) . Expression of Hsps is induced in mammalian cells in response to a variety of biological stresses, including not only high temperature but also viral infections, toxic chemicals, inflammation, malignant tumors, and alcohol. However, Hsps are present in significant amounts in non-stressed cells, implying some physiological roles of these proteins in normal cellular functions. Hsps are known as chaperones that assist a variety of proteins in their folding, assembly and stabilization at birth, their transport within the cell, and even their death and degradation. Moreover, Hsps are suggested to be expressed in association with cellular apoptosis.
Among the Hsps, the 27-and 70-kDa Hsps (Hsp27 and Hsp70, respectively) have been localized to the hypertrophic chondrocytes, but not to the proliferating or resting chondrocytes in the growth plate of young adult rats (Otsuka et al. 1996 , Vanmuylder et al. 1997 , implying involvement of these Hsps in chondrocyte differentiation and degeneration during endochondral ossification. In Meckel's cartilage, a previous report demonstrated that Hsp70 is distributed diffusely in the chondrocytes throughout the life of the cartilage, suggesting a role of Hsp70 in Meckel's cartilage that is not restricted to the degeneration of chondrocytes (Trichilis and Wroblewski 1997) .
In the present study, we aimed to elucidate the roles of Hsp25, a mouse homologue of Hsp27, in Meckel's cartilage during the development of mouse mandible. We first examined, using immunohistochemistry, the temporal and spatial occurrence of Hsp25 in Meckel's cartilage and compared it with other embryonic and adult cartilages in mice. Thereafter, we examined the effect of the antisense oligonucleotide for Hsp25 on the development of Meckel's cartilage using the organ culture system of mouse mandibles.
Materials and methods

Animals
Pregnant time-mated ddY mice were purchased from Japan SLC Ltd. (Hamamatsu, Japan). The day a vaginal plug appeared was designated as embryonic day 0 (E0). At E10, E11, E12, E14, E15, E16 and E17, the pregnant animals were anesthetized with an intraperitoneal injection of sodium pentobarbital (50 mg/kg body weight), and their uteri were taken out and placed in cold Hanks' medium (Nissui, Tokyo, Japan). Under a dissection microscope, embryos were carefully collected from the uteri and their membranes were discarded. The embryos were fixed and processed for morphological analyses. Some E10 embryos were further microdissected for the organ culture of mandibles. New born (P0) and young adult (8-week-old) mice were also used.
Organ culture and antisense inhibition
A 15-bp oligodeoxyribonucleotide (ODN) with the sequence 5′-CAC GCG GCG CTC GGT-3′, in which three bases at both ends were phosphorothioated, was purchased from Japan BioService Co. (Asaka, Japan) for use in the antisense inhibition experiment. This antisense-Hsp25 ODN is complementary to the sequence encompassing 11-25 bp downstream of the translation initiation site in the published mouse Hsp25 cDNA sequence (Gaestel et al. 1900) . The corresponding control (sense) ODN for Hsp25 was also prepared. Both the antisense and sense ODN proved to have no significant homology with other mouse cDNA on GenBank database.
Mouse mandibles were cultured in a serum-free, chemically defined medium according to the methods established (Shum et al. 1993; Chai et al. 1994 ) and adopted in our previous studies (Amano et al. 1999; Amano et al. 2002) . E10 ddY mouse embryos at Theiler's stage 18 (Theiler 1972) were isolated and the mandibular divisions of the first branchial arch were microdissected and explanted. Each explant was supported by a Millipore type AABP filter with 0.8-µM pore size and 5-mm diameter, and five to seven explants for each experimental condition were placed on a steel raft in a Falcon organ-culture dish. They were cultured in BGJb medium (Fitton-Jackson's modified BGJ; Gibco BRL, Grand Island, N.Y.) freshly supplemented with 100 µg/ml ascorbic acid and 100 U/ml penicillin-streptomycin (Gibco BRL) and adjusted to pH 7.4, in an atmosphere of 5% CO 2 and 95% air with 100% humidity at 37°C for 10 days. To deprive the synthesis of endogenous Hsp25 in the cultured mandibles, 25 µM antisense Hsp25-ODN or sense ODN was added to the culture medium at the beginning of the culture. The medium was changed every other day, and ODNs were supplemented with new medium every time. All experiments were performed with triplicate or more samples and repeated at least three times.
Antibody and Western blotting
Rabbit polyclonal antibody against mouse Hsp25 was purchased from StressGen Biotechnology Corporation (Victoria, Canada). The specificity of this antibody was examined by Western blotting according to the method described in our previous study . Briefly, the recombinant human Hsp27 (0.1 µg, StressGen) and the homogenate of limb skeletal muscle from newborn mice (10 µg protein) were separated by SDS-polyacrylamide gel electrophoresis in the presence of 0.1% SDS. They were then transferred to a PVDF membrane (Bio-Rad Laboratories, Hercules, Calif.) and incubated with 2.5 µg/ml anti-Hsp25 antibody overnight. The immunoreaction was made visible using a labeled streptavidin-biotin (LSAB)-alkaline phosphatase kit (Dako, Glostrup, Denmark).
Histology and immunohistochemistry
Mice at E10, E11, E12, E14, E15, E16, E17, and postnatal day 0 (P0) as well as adult mice, and groups of three or more E10 mandibles cultured for 10 days under various conditions were subjected to morphological analyses. To make frozen sections for immunohistochemistry, the mandibles and other specimens were fixed in 4% paraformaldehyde in 0.1 M phosphate buffer for 4 h and then immersed in the phosphate buffer containing 30% sucrose. The adult specimens were decalcified in 5% EDTA for 7 days. The specimens were then frozen, cut into 15 µM sections on a cryostat and mounted on silane-coated glass slides. To make serial sections for hematoxylin-eosin (HE) staining and immunohistochemistry, the specimens were fixed in Bouin's solution for 4 h at 4°C. They were then dehydrated in ethanol series. Consecutive sections of 5-µM thickness were cut from each paraffin block and mounted on silane-coated glass slides.
Immunohistochemistry was performed with cryostat and paraffin sections according to the method described in our previous studies Yamamoto et al. 2001) . Briefly, the sections were incubated successively with 0.3% Tween 20 in PBS for 1 h, 0.3% hydrogen peroxide in methanol for 10 min, and with 3% normal porcine serum in PBS for 30 min and with the anti-Hsp25 antibody (diluted 1:1,000 in PBS) overnight at room temperature. They were then incubated for 3 h at room temperature with horseradish peroxidase-conjugated anti-rabbit IgG (EnVision, Dako). The site of immunoreaction was made visible with 0.01% 3,3'-diaminobenzidine tetrahydrochloride (Daido, Tokyo, Japan) and 0.002% hydrogen peroxide in 0.05 M TRISHCl (pH 7.6). For immunohistochemical control, the antibody preabsorbed with 1 µg/ml recombinant human Hsp27 was used as primary antibody.
In situ hybridization histochemistry RNA probes (riboprobes) for Hsp25 were prepared as described in our previous paper . Briefly, a 533-bp cDNA fragment covering a portion of the coding sequence of rat Hsp27 cDNA (GenBank, M86389) was cloned into pGEM3Zf (+) plasmid (Promega, Madison, Wis.). This rat cDNA had a 93% sequence homology with the corresponding portion of mouse Hsp25 cDNA (GenBank, XM_109446). To generate the antisense and sense riboprobes, the plasmid was linealized and transcribed in vitro with T7 and SP6 polymerases (Toyobo, Osaka, Japan), respectively, in the presence of digoxigenin-conjugated UTP (Roche Diagnostics, Mannheim, Germany).
In situ hybridization was performed as described in our previous study . Briefly, the cryostat sections were treated successively with 2 µg/ml proteinase K, 0.2 N HCl and 0.25% acetic anhydride. They were then prehybridized in a mixture composed of 50% deionized formamide, 2× SSC, 10 mM TRIS-HCl (pH 8.0), 1 mM EDTA, 0.25% SDS, 1× Denhardt's solution and 200 µg/ml tRNA for 2 h at room temperature. Hybridization was performed at 50°C with the hybridization mixture containing digoxigenin-labeled antisense or sense Hsp25 probe and 10% (W/V) dextran in addition to the components of the prehybridization mixture. After 16-24 h, the sections were washed successively with 50% formamide/2× SSC, 20 µg/ml RNase A (Roche Diagnostics), 2× SSC and 0.2× SSC. The site of hybridization was made visible immunohistochemically using alkaline-phosphataseconjugated sheep anti-digoxigenin antibody (Roche Diagnostics) and BCIP/NBT substrate system (Dako).
Whole mount staining
At the termination of the organ culture experiments, the cultured mandibles were subjected to whole mount staining with Alcian blue to examine the three-dimensional architecture of Meckel's cartilage according to the previous studies (Shum et al. 1993; Chai et al. 1994) . Alcian blue specifically stains the chondroitin sulfate component of cartilage. Briefly, explants were gently isolated from the filters, washed in PBS, and incubated overnight with 10% (w/v) Alcian blue (Wako, Kyoto) and 20% glacial acetate in ethanol. They were then hydrated through graded ethanols (95%, 90%, 80%, 70%, 50% and 30%), each for 30 min twice, and finally in distilled water. The specimens were then incubated in 1% potassium hydroxide for 1 h to wash off excessive staining and were examined under dissection microscope.
Results
Definition of the portions of Meckel's cartilage
The terminology describing the portions of Meckel's cartilage is confusing among studies (Bhaskar et al. 1953; Melcher 1972; Savostin-Asling and Asling 1973; Ishizeki et al. 1997 Ishizeki et al. , 1999 . In the present study, Meckel's cartilage was divided into three portions according to the description by Savostin-Asling and Asling (1973) with some modifications: (1) the anterior portion constituting the distal or rostral regions of the cartilage that is replaced with mandibular bone at later embryonic stages; (2) the intermediate portion that gives rise to sphenomandibular ligament; and (3) the posterior portion constituting the proximal or caudal regions of the cartilage that finally gives rise to malleus and its anterior ligament.
Specificity of anti-Hsp25 antibody
Western blotting analysis using anti-Hsp25 antibody demonstrated a single band of 25 kDa with both human recombinant Hsp27 and the homogenate of limb skeletal muscles from newborn mice (Fig. 1) , indicating the specific binding of this antibody to mouse Hsp25. The paraffin and frozen sections from embryonic and postnatal specimens were examined with the same immunohistochemical procedure. No differences were noted between the frozen and paraffin sections from embryonic tissues, whereas the paraffin sections from decalcified adult tissues failed to immunodetect Hsp25 in cartilage. Therefore, we used paraffin and frozen sections for embryonic tissues and frozen sections for decalcified tissues.
At E12, a mesenchymal condensation forming Meckel's cartilage was found bilaterally between the margin of ectoderm and the intermediate muscle layer undergoing tongue formation (Fig. 2a) . Faint immunoreactivity for Hsp25 was detected in the mesenchymal cells within the condensation, whereas the ectoderm forming dermis and pharyngeal mucosa, and the myoblasts forming intra-and extra-mandibular muscles exhibited moderate Hsp25 immunoreactivity (Fig. 2b, c) . In the control sections immunostained with the antibody preabsorbed with human Hsp27 antigen, no specific staining was obtained (not shown).
At E13, the intermediate portions of Meckel's cartilage had developed and well-differentiated chondrocytes were observed in the cartilaginous bars surrounded by perichondrium (Fig. 3a) . Hsp25 immunoreactivity with moderate intensity was observed in the cytoplasm of the chondrocytes in Meckel's cartilage (Fig. 3b) . Cartilage matrix and perichondrium were immunonegative.
At E14, Meckel's cartilage showed the appearance of mature cartilage, in which chondrocytes in lacunae were dispersed among the homogeneous cartilage matrix. The chondrocytes showed both resting and proliferating profiles in all portions of the cartilage. Many chondrocytes showed intense immunoreactivity for Hsp25 in the anterior and intermediate portions of Meckel's cartilage, whereas the chondrocytes in the posterior portion were faintly or negatively immunopositive for Hsp25 (Fig. 4a-d) . The mesenchymal cells undergoing membranous ossification for mandibular bone were negative for Hsp25 (Fig. 4e) . In the sections hybridized with digoxigenin-labeled antisense Hsp25 riboprobe, the staining representing the signal for Hsp25 mRNA was localized to the chondrocytes in the anterior and intermediate portions of Meckel's cartilage (Fig. 4f) . In the control sections hybridized with the sense probe, no specific staining was obtained (not shown).
At E15, chondrocytes of Meckel's cartilage continued to show Hsp25 immunoreactivity, but its intensity had weakened substantially (not shown).
At E16, many hypertrophic chondrocytes had appeared in the intermediate portion of Meckel's cartilage, and the area occupied by the cartilaginous tissue was being replaced by developing lower incisor tooth germ and mandibular bone. Hsp25 immunoreactivity had disappeared from most of the chondrocytes in all portions of Meckel's cartilage (Fig. 5a ). The immunonegative chondrocytes showed both resting and hypertrophic profiles (Fig. 5b) .
At E17, the intermediate portion of Meckel's cartilage had disappeared, leaving only the V-shaped anterior portion and the separated bilateral posterior portion. No Hsp25 immunoreactivity was noted in the hypertrophic chondrocytes at any portion of the remaining Meckel's cartilage (Fig. 5c) .
At P0, most part of the posterior portion of Meckel's cartilage was undergoing endochondral ossification to form incus and malleus adjacent to the developing temporal bone. The hypertrophic chondrocytes in the process of endochondral ossification were moderately immunoreactive for Hsp25 (Fig. 5d) . In other mandibular regions, Meckel's cartilage had completely disappeared.
Immunohistochemical localization of Hsp25 in other embryonic and adult cartilages No Hsp25 immunoreactivity was detected in the cartilaginous templates for cranial base, vertebrae, limbs and digits, before they began to ossify. After the onset of ossification around E15 (Rugh 1990) , the portions of those cartilaginous templates undergoing endochondral ossification showed moderate Hsp25 immunoreactivity that was localized mainly in the hypertrophic chondrocytes (Fig. 6a, b) .
The embryonic vertebral column consists of the fibrous nucleus pulpous and the cartilaginous tissue undergoing endochondral ossification (Fawcett 1986 ). Hsp25 immunoreactivity was localized intensely in the mesenchymal cells of pulpous nuclei, and moderately in the hypertrophic chondrocytes at the sites of endochondral (Fig. 6c) . In both immunopositive cell types, the immunoreactivity was localized to the cytoplasm. In adults, the intervertebral discs developed from pulpous nuclei, the embryonic cartilaginous tissue surrounding pulpous nuclei, and the vertebral bone were completely immunonegative for Hsp25 (not shown).
Hsp25 immunoreactivity was observed in the growth plate in the knee joints of 8-week-old mice, and was localized to the chondrocytes in the upper layers of hypertrophic zone, whereas those in the resting and proliferating zones were immunonegative (Fig. 6d) . This pattern of Hsp25 distribution in growth plate is the same as that reported in adult rats (Otsuka et al. 1996; Vanmuylder et al. 1997; Tiffee et al. 2000) . In contrast, chondrocytes in the articular cartilage showed no Hsp25 immunoreactivity (Fig. 6e) .
Laryngeal and tracheal cartilages (representing cartilages that never undergo ossification throughout the animal life) were moderately immunostained for Hsp25, from embryonic through adult ages. The immunoreactivity was localized to the hypertrophic chondrocytes located preferentially in the center of the cartilages (Fig. 6f) . In contrast, the proliferating and resting chondrocytes were immunonegative.
Besides the cartilaginous tissues, the dermis and muscular tissues were intensely immunopositive for Hsp25 in all embryonic stages examined in the present study (Figs. 2a, 3a, 4a, 5a, 6a) . These results agreed with our previous study performed in adult mice (Wakayama and Iseki 1998) .
Effect of antisense ODN for Hsp25 in the organ culture of embryonic mandibles E10 mandibles cultured for 10 days with serum-free medium showed normal tissues corresponding to those of E15 in vivo, including the epithelium, Meckel's cartilage, developing mandibular bone, and developing tongue both in HE-stained serial sections and in whole-mount specimens stained with Alcian blue for cartilage (Shum et al. 1993; Chai et al. 1994; Amano et al. 1999) .
In the present study, when the explants were cultured in the control medium without ODN for 10 days, Meckel's cartilage with normal appearance had developed in the whole-mount specimens (Fig. 7a) . When the explants were cultured in the presence of antisense Hsp25 ODN, apparent defects of Meckel's cartilage were noted by whole-mount staining (Fig. 7b) . The anterior to intermediate portions of Meckel's cartilage were completely lacking, while the posterior portion had been formed normally. In contrast, sense Hsp25 ODN had no effect on the development of Meckel's cartilage (Fig. 7c) . These deformities were confirmed in serial sections. The cartilaginous tissue in the anterior and intermediate portions of Meckel's cartilage in the control explants was replaced with mesenchymal components in the explants cultured with the antisense ODN (Fig. 7d) , whereas mandibular bone formation appeared normal compared with the control explants. In contrast, sense Hsp25 ODN had no effect on the normal histology of Meckel's cartilage (Fig. 7e) . 
Discussion
Much knowledge has accumulated recently on the molecular mechanisms underlying chondrocyte proliferation and differentiation. Members of the bone morphogenic protein (BMP) and basic fibroblast growth factor (bFGF) signaling molecule families as well as parathyroid hormone-related peptide (PTHrP), Indian hedgehog (Ihh), and Sox9 have been examined and proposed to be among the key regulatory molecules in chondrogenesis (Iwamoto et al. 1991; Crombrugghe et al. 2001; Haudenschild et al. 2001; Minina et al. 2001 ). Hsp25 and Hsp70, being expressed in the hypertrophic chondrocytes in the growth plate, have been implicated in the 169 Fig. 6 Immunohistochemical localization of Hsp25 in the cartilaginous anlagen of digital bone (a, b) and vertebral bone (c) of E17 mice, in the growth plates (d) and articular cartilage (e) of knee joints, and in laryngeal cartilage (f) of adult mice. In the developing digits, the ossifying cartilage indicated by the rectangular (a) is shown at a higher magnification in (b). Note that only the hypertrophic chondrocytes (arrowheads) are immunoreactive for Hsp25, whereas the resting and proliferating chondrocytes are immunonegative. In the developing vertebral bone, Hsp25 is restricted to the hypertrophic chondrocytes (arrows) in addition to the fibrous nucleus pulpous (asterisks). In knee joints of adult mice, Hsp25 is present in the hypertrophic chondrocytes (arrows) but is absent from the resting and proliferating chondrocytes (arrowheads) in the growth plates (d), and is also absent from any chondrocytes in articular cartilage (e). The hypertrophic chondrocytes in the center of laryngeal cartilage show Hsp25-immunoreactivity (f). a ×4; b, c ×10; d-f ×20 terminal differentiation of cartilages (Otsuka et al. 1996; Vanmuylder et al. 1997 ).
Meckel's cartilage, however, is unique among a variety of cartilages in that it occurs provisionally prior to the permanent mandibular bone formation in the first branchial arch (Sohal et al. 1999) . Since its first description in a German textbook in the 19th century (Meckel 1820) , two issues concerning Meckel's cartilage remain to be solved. First, does Meckel's cartilage contribute to mandibular bone formation? Second, do hypertrophic chondrocytes in the degenerating cartilage die, or survive? There is no doubt that Meckel's cartilage indirectly contributes to the development of mandibular bone by guiding its direction and size, as well as mechanically, supporting mandibular process before bone formation. However, the direct contribution of Meckel's cartilage to mandibular bone formation by endochondral ossification has been controversial for a long time. Except for the anterior and posterior ends of Meckel's cartilage, which undergo endochondral ossification to form the intermandibular symphysis and middle ear ossicles, respectively (Bhaskar et al. 1953; Bernick and Patek 1969; SavostinAsling and Asling 1973) , most parts of Meckel's cartilage degenerate and consequently are replaced by bone tissue. There has been much debate as to whether this replacement represents endochondral ossification or an independent phenomenon (Melcher 1972; Frommer et al. 1971; Savostin-Asling and Asling 1973) . One important objective of the present study was to shed new light on this problem by comparing the degeneration of Meckel's cartilage with typical endochondral ossification that occurs in the growth plate in adults and in the long bone anlagen in embryos.
The present study has clearly shown Hsp25-immunopositive chondrocytes in many types of cartilage in both embryonic and postnatal mice. These were here classified into three categories: (1) hypertrophic chondrocytes involved in the endochondral ossification, (2) hypertrophic chondrocytes in the permanent cartilage, and (3) immature chondrocytes in Meckel's cartilage. In endochondral ossification, degeneration of chondrocytes is essential for the subsequent vascularization and ossification. In growth plates, the process of endochondral ossification consists of a series of chondrocyte proliferation, hypertrophy (maturation), degeneration and death. The present immunohistochemical results for Hsp25 are consistent with previous results in that Hsp25 is localized to the chondrocytes in zone of hypertrophy at the site of endochondral ossification (Otsuka et al. 1996; Vanmuylder et al. 1997; Tiffee 2000) . The location of zone of hypertrophy between zones of proliferation and calcification implies that the hypertrophic chondrocytes are in the process of switching from proliferation to terminal differentiation. These results raise the possibility that Hsp25 is involved in the cessation of proliferation and the onset of differentiation in chondrocytes. This is consistent with the results in many in vitro systems, including lymphocytes, osteoblasts, promyelocytic leukemia cells, Ehrlich ascites cells, cardiomyocytes, and embryonic stem (ES) cells (reviewed by Morange 1999) . In ES cells, overexpression of Hsp25 enhances the differentiation-associated decrease in cell proliferation, whereas inhibition of Hsp25 expression leads to the continuous cell proliferation and apoptosis (Mehlen et al. 1997) . In vivo, the cells at the transitional phase between proliferation and differentiation express Hsp25 immunoreactivity and/or mRNA in certain tissues, including stratified squamous epithelium of mouse esophagus (Wakayama and Iseki 1998) , seminiferous epithelium of mouse testis (Wakayama and Iseki 1999) , and developing acini of rat submandibular gland . As the mechanism by which Hsp25 functions in cellular transition from proliferation to differentiation in ES cells, Arrigo and Preville (1999) have proposed that Hsp25, through its transient oligomerization during the early cell differentiation, binds to proteins that play a role during cell growth but which are no longer of use in differentiating cells.
The present study has demonstrated the localization of Hsp25 in the hypertrophic chondrocytes of laryngeal and tracheal cartilages, from the embryonic through adult ages. Since these permanent cartilages never undergo endochondral ossification, there may be some molecular mechanism that prevents the hypertrophic chondrocytes of these cartilages from degenerating and dying. Whether Hsp25 expression is involved in such a mechanism is unknown. Hsp25 expression is absent in articular cartilage, which is also a permanent cartilage, except at the temporomandibular joint, where Hsp25 immunoreactivity in the chondrocytes of articular cartilage has already been reported in the adult rat (Nozawa-Inoue et al. 1999) . Since temporomandibular articular cartilage in rodents is known to undergo endochondral ossification throughout life, Hsp25-positive cells probably represent the hypertrophic chondrocytes in endochondral ossification.
To our knowledge, the present study is the first to demonstrate the expression of Hsp25 in Meckel's cartilage. Hsp25 is absent in the hypertrophic chondrocytes during degeneration but is present in the immature, proliferative chondrocytes before the degeneration of Meckel's cartilage. This difference in the patterns of Hsp25 expression between Meckel's cartilage and endochondral ossification suggests that Hsp25 plays different roles in the two systems, and that different mechanisms are operating in the degeneration of chondrocytes in the two systems.
The hypertrophic chondrocytes in degenerating Meckel's cartilage and those in endochondral ossification have common histochemical features, including alkaline phosphatase activity, in addition to common morphological features on light and electron microscopy (Akisaka et al. 1980) . While the hypertrophic chondrocytes in endochondral ossification are considered to die by apoptosis (Vanmuylder et al. 1997; Tiffee et al. 2000) , the fate of the chondrocytes in degenerating Meckel's cartilage is not clear. There are reports that apoptosis also occurs in the chondrocytes of degenerating Meckel's cartilage (Trichilis and Wroblewski 1997) . On the other hand, Akisaka (1982) demonstrated thiamine pyrophosphatase activity, an osteoblastic marker, in the Golgi apparatus of hypertrophic chondrocytes in degenerating Meckel's cartilage, and proposed that these chondrocytes may survive and transdifferentiate to bone cells. Furthermore, Ishizeki et al. (1996a Ishizeki et al. ( , 1996b Ishizeki et al. ( , 1996c Ishizeki et al. ( , 1998 Ishizeki et al. ( , 1999 demonstrated, using a cell culture model, that the chondrocytes of Meckel's cartilage can transdifferentiate in vitro to osteogenic cells as characterized by their electron microscopic morphology and production of type I collagen. Whatever the fate of the chondrocytes in Meckel's cartilage, the degenerating Meckel's cartilage differs from the cartilage undergoing endochondral ossification in that the extensive vascularization that introduces osteogenic cells into the cartilage matrix is lacking in the former (Ishizeki et al. 1999 ). The present results showing different patterns of chondrocyte Hsp25 expression between Meckel's cartilage and the cartilage in endochondral ossification has reinforced the notion that degeneration of Meckel's cartilage represents a different process from endochondral ossification.
Hsp25 expression in Meckel's cartilage at E12-15, i.e., before the onset of the degeneration period, suggests that Hsp25 plays a role in the development of Meckel's cartilage, which consists of differentiation of chondroblasts from the chondrogenic mesenchymal condensation, proliferation and differentiation of chondroblasts into chondrocytes, and proliferation and matrix synthesis of chondrocytes. This is strongly supported by the antisense inhibition experiment in cultured mandibles, which shows that deprivation of Hsp25 leads to malformation of Meckel's cartilage. Both the frequency of Hsp25-immunopositive chondrocytes and the inhibitory effect of antisense ODN on the cartilage formation are higher in the anterior and intermediate portions of Meckel's cartilage, which undergo degeneration later, than in the posterior portion, which subsequently undergoes endochondral ossification. These results imply that Hsp25 is involved not only in the development of the anterior and intermediate portions of Meckel's cartilage but also in the determination of their fate to degenerate and disappear in a manner differing from that for endochondral ossification.
In contrast to Hsp70, which is expressed in all chondrocytes in Meckel's cartilage throughout the embryonic stages (Trichilis and Wroblewski 1997) , Hsp25 is expressed preferentially in the immature chondrocytes in the anterior and intermediate portions of Meckel's cartilage up to E15 but disappears rather abruptly by E16, prior to onset of the degeneration period. These results suggest that Hsp25 is no longer of use in the process of chondrocyte hypertrophy and degeneration that is specific to Meckel's cartilage, and has no biological role in the conversion of chondrocytes from proliferation to differentiation that is postulated in endochondral ossification. In Meckel's cartilage, no cellular apoptosis is found before E15 except in the perichondrium (Trichilis and Wroblewski 1997) . Considering the coincidence of Hsp25 expression and the lack of apoptosis in chondrocytes, it seems reasonable to assume that Hsp25 contributes to inhibiting chondrocyte apoptosis in immature Meckel's cartilage, and that the decline in the expression of Hsp25 elicits onset of the degeneration of Meckel's cartilage. The continuous expression of Hsp25 in the permanent cartilages in larynx and trachea also supports the anti-apoptotic function of Hsp25 in cartilages. Several mechanisms have been postulated for the anti-apoptotic function of Hsp25: Hsp25 negatively regulates apoptosis by counteracting FAS/APO-1 or staurosporineinduced programmed cell death (Mehlen et al. 1996) , or by interacting with cytochrome C in the caspase-dependent pathway (Bruey et al. 2000) . In the ES cell model, underexpression of Hsp25 attenuates proliferation and induces abortion of the differentiation process by apoptosis (Mehlen et al. 1997) .
Hsp25 is known to bind specifically to the actin molecule and to modulate actin filament dynamics (Lavoie et al. 1993) . Similarly, Hsp25 has been shown to have a molecular chaperon activity in vitro for aggrecan, a major proteoglycan core protein of cartilage (Zheng et al. 1998; Luo et al. 2000) . In endochondral ossification, however, aggrecan is reported to be distributed in all zones (Tiffee et al. 2000) , or all zones except for zone of proliferation (Pacifici 1994) . Therefore, the specific localization of Hsp25 to the zone of hypertrophy does not agree with the hypothesis that Hsp25 functions in modulating aggrecan synthesis and/or function in endochondral ossification. So far, there is no report on the spatial and temporal localization of aggrecan in Meckel's cartilage. Further study is necessary to examine possible relation between Hsp25 and aggrecan in Meckel's cartilage.
Meckel's cartilage follows a fate that is different from the cartilage undergoing endochondral ossification and from the permanent cartilage. Unlike in the latter two cartilages where Hsp25 is expressed only in the mature, hypertrophic chondrocytes, Hsp25 in Meckel's cartilage is expressed only in the immature, still proliferating chondrocytes. It seems an attractive hypothesis that the commitment of chondrocytes to the different fates is determined during their immature phase, and the precocious and temporary expression of Hsp25 in the immature chondrocytes commit them to a fate specific to Meckel's cartilage.
